Go2 Foundation For Lung Cancer
Go2 Foundation For Lung Cancer shows strong revenue growth and asset accumulation with no reported officer compensation.
EIN: 204417327 · Washington, DC · NTEE: G12 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $25.3M |
| Total Expenses | $13.8M |
| Program Spending | 80% |
| CEO/Top Officer Pay | $17 |
| Net Assets | $16.2M |
| Transparency Score | 90/100 |
Is Go2 Foundation For Lung Cancer Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Go2 Foundation For Lung Cancer directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Go2 Foundation For Lung Cancer
Go2 Foundation For Lung Cancer (EIN: 204417327) is a nonprofit organization based in Washington, DC, classified under NTEE code G12. The organization reported total revenue of $25.3M and total assets of $17.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Go2 Foundation For Lung Cancer's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Go2 Foundation For Lung Cancer is a large nonprofit that has been operating for 20 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 15.6%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $12.8M |
| Total Expenses | $13.8M |
| Surplus / Deficit | $-992,927 |
| Total Assets | $21.0M |
| Total Liabilities | $4.7M |
| Net Assets | $16.2M |
| Operating Margin | -7.8% |
| Debt-to-Asset Ratio | 22.6% |
| Months of Reserves | 18.2 months |
Financial Health Grade: B
In 2023, Go2 Foundation For Lung Cancer reported a deficit of $993K with expenses exceeding revenue, holds 18.2 months of operating reserves (strong position), has a debt-to-asset ratio of 22.6% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Go2 Foundation For Lung Cancer's revenue has grown at a compound annual growth rate (CAGR) of 15.6%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -15.8% | +10.3% | -6.3% |
| 2022 | +10.2% | +7.0% | +36.2% |
| 2021 | -1.0% | +12.4% | +25.7% |
| 2020 | +63.9% | +2.2% | +34.1% |
| 2019 | +60.3% | +75.8% | +200.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2006 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Go2 Foundation For Lung Cancer with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 12%
- programs: 80%
- fundraising: 8%
According to IRS 990 filings, Go2 Foundation For Lung Cancer allocates its expenses as follows: admin: 12%, programs: 80%, fundraising: 8%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $993K, with expenses exceeding revenue.
- Debt-to-asset ratio: 22.6%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that the organization's officers are not directly compensated, which is highly unusual for an organization of its size with assets exceeding $17 million.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Go2 Foundation For Lung Cancer's IRS 990 filings:
- Slight decrease in net assets from 202212 to 202312 (from $22,362,320 to $20,963,444), though overall trend is positive.
Strengths
The following positive indicators were identified for Go2 Foundation For Lung Cancer:
- Consistent and significant revenue growth over the past decade.
- Substantial growth in assets, indicating strong financial health.
- Remarkable 0% reported officer compensation across all filings, suggesting high efficiency and dedication.
- Robust filing history with 13 IRS 990 filings, demonstrating transparency.
- Liabilities are well-managed relative to assets.
Frequently Asked Questions about Go2 Foundation For Lung Cancer
Is Go2 Foundation For Lung Cancer a legitimate charity?
Go2 Foundation For Lung Cancer (EIN: 204417327) is a registered tax-exempt nonprofit based in Washington DC. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $25.3M. 1 red flag identified. 5 strengths noted. Financial health grade: B.
How does Go2 Foundation For Lung Cancer spend its money?
Go2 Foundation For Lung Cancer directs 80% of its spending to programs and services. Fundraising costs 8%. This exceeds the 65% industry benchmark.
Are donations to Go2 Foundation For Lung Cancer tax-deductible?
Go2 Foundation For Lung Cancer is registered as a tax-exempt nonprofit (EIN: 204417327). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Go2 Foundation For Lung Cancer CEO make?
Go2 Foundation For Lung Cancer's highest-compensated officer earns $17 annually. The organization reported $25.3M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Go2 Foundation For Lung Cancer's spending goes to programs?
Go2 Foundation For Lung Cancer directs 80% to programs, 8% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Go2 Foundation For Lung Cancer compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Go2 Foundation For Lung Cancer is above average for NTEE category G12 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Go2 Foundation For Lung Cancer located?
Go2 Foundation For Lung Cancer is headquartered in Washington, Washington DC and files with the IRS under EIN 204417327. It is classified under NTEE code G12.
How many years of IRS 990 filings does Go2 Foundation For Lung Cancer have?
Go2 Foundation For Lung Cancer has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $25.3M in total revenue.
Is Go2 Foundation For Lung Cancer a good charity?
Based on the available IRS 990 data, Go2 Foundation For Lung Cancer appears to be a good charity. It demonstrates strong financial health with consistent revenue growth, substantial assets, and a remarkable 0% reported officer compensation, indicating a high level of financial efficiency and donor trust.
How has Go2 Foundation For Lung Cancer's revenue trended?
Go2 Foundation For Lung Cancer has shown significant revenue growth over the past decade, increasing from $3,370,749 in 201612 to a latest reported revenue of $25,269,471, with consistent increases year-over-year in most periods.
What is the organization's asset growth like?
The organization's assets have grown substantially, from $3,236,528 in 201812 to $17,189,128 currently, reaching a peak of $22,362,320 in 202212, indicating strong financial accumulation.
Are there any concerns about executive pay?
No, there are no concerns about executive pay; in fact, the organization consistently reports 0% for Officer Compensation across all filings, which is an exceptional indicator of financial prudence and dedication to mission.
Filing History
IRS 990 filing history for Go2 Foundation For Lung Cancer showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Go2 Foundation For Lung Cancer's revenue has grown by 468.3%, moving from $2.3M to $12.8M. Total assets increased by 1632.5% over the same period, from $1.2M to $21.0M. Total functional expenses rose by 526.4%, from $2.2M to $13.8M. In its most recent filing year (2023), Go2 Foundation For Lung Cancer reported a deficit of $993K, with expenses exceeding revenue. The organization holds $4.7M in liabilities against $21.0M in assets (debt-to-asset ratio: 22.6%), resulting in net assets of $16.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $12.8M | $13.8M | $21.0M | $4.7M | — | — |
| 2022 | $15.2M | $12.5M | $22.4M | $5.2M | — | View 990 |
| 2021 | $13.8M | $11.7M | $16.4M | $2.0M | — | View 990 |
| 2020 | $13.9M | $10.4M | $13.1M | $722K | — | — |
| 2019 | $8.5M | $10.2M | $9.7M | $970K | — | View 990 |
| 2018 | $5.3M | $5.8M | $3.2M | $1.1M | — | View 990 |
| 2017 | $4.4M | $4.6M | $3.5M | $902K | — | View 990 |
| 2016 | $3.4M | $4.7M | $4.1M | $1.2M | — | View 990 |
| 2015 | $4.3M | $3.7M | $4.3M | $85K | — | View 990 |
| 2014 | $5.4M | $2.7M | $3.7M | $111K | — | View 990 |
| 2013 | $3.2M | $2.8M | $979K | $88K | — | View 990 |
| 2012 | $2.5M | $2.8M | $717K | $253K | — | View 990 |
| 2011 | $2.3M | $2.2M | $1.2M | $570K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $12.8M, expenses of $13.8M, and assets of $21.0M (revenue -15.8% year-over-year).
- 2022: Revenue of $15.2M, expenses of $12.5M, and assets of $22.4M (revenue +10.2% year-over-year).
- 2021: Revenue of $13.8M, expenses of $11.7M, and assets of $16.4M (revenue -1.0% year-over-year).
- 2020: Revenue of $13.9M, expenses of $10.4M, and assets of $13.1M (revenue +63.9% year-over-year).
- 2019: Revenue of $8.5M, expenses of $10.2M, and assets of $9.7M (revenue +60.3% year-over-year).
- 2018: Revenue of $5.3M, expenses of $5.8M, and assets of $3.2M (revenue +21.7% year-over-year).
- 2017: Revenue of $4.4M, expenses of $4.6M, and assets of $3.5M (revenue +29.3% year-over-year).
- 2016: Revenue of $3.4M, expenses of $4.7M, and assets of $4.1M (revenue -21.3% year-over-year).
- 2015: Revenue of $4.3M, expenses of $3.7M, and assets of $4.3M (revenue -20.9% year-over-year).
- 2014: Revenue of $5.4M, expenses of $2.7M, and assets of $3.7M (revenue +67.4% year-over-year).
- 2013: Revenue of $3.2M, expenses of $2.8M, and assets of $979K (revenue +29.9% year-over-year).
- 2012: Revenue of $2.5M, expenses of $2.8M, and assets of $717K (revenue +10.6% year-over-year).
- 2011: Revenue of $2.3M, expenses of $2.2M, and assets of $1.2M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Go2 Foundation For Lung Cancer:
Data Sources and Methodology
This transparency report for Go2 Foundation For Lung Cancer is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.